Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Liver Damage Linked to Brain Magnetite Accumulation
July 2025
Using superconducting quantum interference device magnetometry, researchers examined the magnetic properties of post-mortem brainstem tissue from four individuals.
Read more
16 Jun 2025
Non-Diabetic Metabolic Dysfunction Increases Liver Fibrosis Risk
This study explored the effects of various metabolic abnormalities, such as central obesity, high blood pressure, and elevated high-sensitivity C-reactive protein (hsCRP), on liver steatosis and fibrosis.
14 Jun 2025
Reducing Alcohol Consumption to Prevent Liver Disease Globally
Discover more about strong evidence that public health measures, such as raising alcohol prices and restricting access can significantly reduce alcohol consumption.
13 Jun 2025
Dapagliflozin Emerges as Potential MASH Therapy in Landmark Study
Dapagliflozin shows promise for treating MASH, improving liver outcomes without worsening fibrosis in a major trial.
12 Jun 2025
Tackling Silent Liver Disease: A Global Health Priority
A 2023 global call to action by over 300 experts highlighted the need for clear, cross-specialty care pathways to support earlier identification and referral of people at risk.
8 Jun 2025
Efruxifermin Improves Fibrosis in Long-Term MASH Study
In this double-blind, placebo-controlled trial, 181 participants were randomised to receive weekly injections of either 28 mg or 50 mg of efruxifermin or a placebo.
6 Jun 2025
National Study Reveals Gaps in Paediatric Hepatitis C Treatment
These figures indicate a substantial drop-off following diagnosis, undermining efforts to eliminate HCV in paediatric populations.
4 Jun 2025
AI Tool Accurately Predicts Liver Graft Injury Causes
The model analyses demographic information, lab results, and other clinical data to predict the cause of graft injury across six possible conditions.
2 Jun 2025
Extracellular Volume Fraction Predicts Cirrhosis Severity Accurately
This new study highlights the growing role of extracellular volume measurement using spectral CT, which quantifies the proportion of extracellular matrix.
Loading posts...
« Previous
1
2
3
4
5
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View